Daily Market Research Report

January 08, 2026

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM

This report is generated using advanced AI research capabilities with real-time market data access.

Gold ETFs: Institutional Outlook (as of January 8, 2026)

Trading Idea: Buy Rationale (TL;DR): Most top research houses (Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA, HSBC, Deutsche Bank) remain structurally bullish into 2026—projecting ~$4,450–$5,000+/oz—driven by central‑bank/ETF demand and easier policy; only Citi is notably cautious. (straitstimes.com)

Gold rose ~64% in 2025 to record highs; consensus for 2026 is further gains but with wider two‑way volatility amid policy/geopolitical uncertainty and evolving Fed dynamics. (reuters.com)

Key Drivers - Persistent official‑sector (central bank) buying and renewed ETF inflows support elevated prices. (jpmorgan.com) - Falling policy rates/lower real yields and potential dollar softness reduce gold’s opportunity cost. (reuters.com) - Portfolio diversification/de‑dollarization themes and geopolitical risk premium. (finance.yahoo.com) - Tight physical markets; supply response constrained; investment demand absorbing supply. (investing.com)

Risk Considerations - Fewer/faster‑reversed Fed cuts or a stronger USD sap bullion demand. (reuters.com) - ETF outflows or a slowdown/reversal in central‑bank purchases. (finance.yahoo.com) - Normalization of geopolitical/trade risks and better global growth reduce safe‑haven bids. (investing.com) - High prices spur recycling/supply, while jewelry demand weakens; position/range risk remains elevated. (ft.com)

Bias long GLD/IAU/BAR with expectation of continued, but choppy, upside in 2026; accumulate on pullbacks and size positions for volatility. Liquidity needs may favor GLD; fee sensitivity may favor IAU/BAR. Monitor Fed path, USD, ETF flows, and central‑bank purchases closely.

Stock Ratings

Error retrieving stock ratings information: Connection error.

IPO Calendar

Timeframe: January 8 to February 8, 2026 (US equity markets)

A light start is typical after the holidays, and 2026 is no exception: the only firmly scheduled operating-company deal for the first week is biotech Aktis Oncology, with several larger issuers poised to launch once the SEC review process and market windows line up. Notable themes: a potential rebound in biotech issuance; sizeable corporate carve‑outs (e.g., Medtronic’s MiniMed); and a pipeline of capital‑intensive/AI‑enabled operators and crypto/fintech names (EquipmentShare, Motive, BitGo, PicPay). Renaissance Capital expects activity to pick up as January progresses, with the broader 2026 pipeline remaining robust. (renaissancecapital.com)

Aktis Oncology, Inc. (AKTS)

• Expected listing date: January 9, 2026 (expected)
• Price range: $16 – $18
• Shares offered: 17.7 million shares (upsized from 11.8M)
• Exchange: Nasdaq
• Lead underwriters: J.P. Morgan, BofA Securities, Leerink Partners, TD Cowen
• Business summary: Clinical‑stage biotech developing alpha‑emitting radiopharmaceuticals for prevalent solid tumors; lead program AKY‑1189 (targets Nectin‑4) is in Phase 1b, with a second program targeting B7‑H3 advancing toward IND.
• Notes: Eli Lilly indicated interest in ~$100 million of the deal; terms were upsized on January 7. Expected to price/trade around Friday, January 9, 2026, subject to market conditions. (reuters.com)
• Sources: SEC S‑1/A (Aktis Oncology), filed January 7, 2026, Reuters: Aktis upsizes IPO; Lilly anchor, January 7, 2026, Renaissance Capital: Aktis sets/raises terms; Jan 5 & Jan 7, 2026

Libera Gaming Operations, Inc. (LBRJ)

• Expected listing date: January 8, 2026 (tentative)
• Price range: $4.00 – $6.00
• Shares offered: ~1.3 million shares (micro‑cap deal)
• Exchange: Nasdaq (applied)
• Lead underwriters: D. Boral Capital (ex‑EF Hutton), Sutter Securities
• Business summary: Japan‑based operator of 11 pachinko and pachislot halls; revenue model includes gaming and non‑gaming (vending/other) sales at hall locations.
• Notes: Very small float; timeline has shifted multiple times since 2024. Listing venue noted as Nasdaq in filings/marketing materials; final timing subject to change. (renaissancecapital.com)
• Sources: SEC F‑1/A (Libera Gaming Operations), 2024–2025 updates, Renaissance Capital: Week Ahead (Jan 2, 2026), Investing.com IPO Calendar (Jan 8, 2026)

EquipmentShare.com Inc. (EQPT)

• Exchange: Nasdaq (applied)
• Lead underwriters: Goldman Sachs, Wells Fargo Securities, UBS Investment Bank, Citigroup, Guggenheim Securities, Citizens JMP, Truist Securities, Baird, Oppenheimer & Co., KeyBanc Capital Markets
• Business summary: Digitally native construction‑equipment rental and services platform with a nationwide footprint; integrates rentals, telematics and jobsite operations via its proprietary T3 platform.
• Notes: Filed an S‑1 on Dec 9, 2025; Renaissance estimates an ~$800 million deal and notes listing could come as early as January 2026, pending market conditions/SEC clearance. Pricing terms not yet disclosed. (sec.gov)
• Sources: SEC S‑1 (EquipmentShare.com Inc.), filed Dec 9, 2025, Renaissance Capital: EquipmentShare files for IPO (Dec 9, 2025), Company press release via Business Wire (Dec 2025)

Motive Technologies, Inc. (MTVE)

• Exchange: NYSE (applied)
• Lead underwriters: J.P. Morgan, Citigroup, Barclays, Jefferies, RBC Capital Markets, Citizens JMP, KeyBanc Capital Markets, SG Americas (Société Générale), Nomura (Wolfe | Nomura Alliance), William Blair, Canaccord Genuity, Needham & Company, Piper Sandler, Raymond James, Academy Securities
• Business summary: AI‑enabled platform for physical operations (fleets, equipment and field workforce) combining telematics hardware (e.g., AI dashcams) with subscription software for safety, compliance and spend management.
• Notes: Public S‑1 filed Dec 23, 2025; ticker MTVE reserved on NYSE. No pricing terms or launch date disclosed yet. (sec.gov)
• Sources: SEC S‑1 (Motive Technologies), filed Dec 23, 2025

MiniMed Group, Inc. (Medtronic Diabetes carve‑out) (MMED)

• Exchange: Nasdaq (applied)
• Lead underwriters: Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley
• Business summary: Global diabetes‑management business (insulin pumps, continuous glucose monitoring systems, consumables and software/services) being separated from Medtronic via IPO and subsequent split‑off.
• Notes: S‑1 filed Dec 19, 2025; company targets an early‑2026 launch window, subject to SEC review and market conditions. Proceeds expected to repay intercompany debt and for general purposes. (sec.gov)
• Sources: SEC S‑1 (MiniMed Group, Inc.), filed Dec 19, 2025, Medtronic press release (Dec 19, 2025), Reuters: MiniMed files; early‑2026 timing (Dec 19, 2025)

PicS N.V. (PicPay) (PICS)

• Exchange: Nasdaq (applied)
• Lead underwriters: Citigroup, BofA Securities, RBC Capital Markets
• Business summary: Brazil’s digital bank/fintech platform offering payments, credit, savings and other financial services to consumers and small businesses; mobile‑first with Pix/QR payments and a large active user base.
• Notes: Filed Form F‑1 on Jan 5, 2026 for a U.S. listing; terms and timing TBD. Second attempt after 2021 postponement. (sec.gov)
• Sources: SEC F‑1 (PicS N.V./PicPay), filed Jan 5, 2026, Reuters: PicPay files for U.S. IPO; Nasdaq ticker PICS (Jan 5, 2026)

BitGo Holdings, Inc. (BTGO)

• Exchange: NYSE (applied)
• Business summary: Crypto‑asset custodian providing secure storage, wallet infrastructure and related services to institutions; manages large balances of BTC, ETH and other assets on platform.
• Notes: Amended S‑1 filed Dec 22, 2025; deal timing not set. Sector sensitivity to crypto market and regulatory backdrop may influence launch window. (sec.gov)
• Sources: SEC S‑1/A (BitGo Holdings, Inc.), filed Dec 22, 2025

Klook Technology Limited (KLK)

• Exchange: NYSE (applied)
• Lead underwriters: Goldman Sachs, J.P. Morgan, Morgan Stanley
• Business summary: APAC‑focused travel experiences marketplace (tours, activities, attractions, transport) planning a U.S. ADS listing.
• Notes: Filed an F‑1 on Nov 10, 2025; no terms or launch date disclosed. Inclusion here reflects likelihood of U.S. pricing once the window opens; exact timing uncertain. (klook.com)
• Sources: Company newsroom: F‑1 filing and proposed NYSE ticker KLK (Nov 10, 2025)

Dates and terms are subject to change; small/micro‑cap offerings frequently shift or withdraw on short notice. Where terms were not disclosed in filings, fields are left null and details are noted in the Notes field. Pipeline names listed as “expected” are included because they filed public registration statements and could launch within the coming month if market windows open; inclusion is not a guarantee of January/early‑February pricing. (renaissancecapital.com)

Sources

• IPO Calendar: https://www.klook.com/newsroom/Form-F-1-public/?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/115899/US-IPO-Week-Ahead-2026-set-to-start-on-a-quiet-note?utm_source=openai, https://www.reuters.com/business/healthcare-pharmaceuticals/aktis-oncology-aims-raise-up-3177-million-upsized-us-ipo-2026-01-07/, https://www.sec.gov/Archives/edgar/data/1646681/000162828025058773/motive-sx1.htm, https://www.sec.gov/Archives/edgar/data/1693736/000162828025055961/eqpt-sx1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1740604/000162828025058587/bitgoholdingsincs-1a3.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/1841644/000121390026001029/ea0201690-17.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/minimedgroupincs-1.htm?utm_source=openai

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2026-01-08 at 11:24 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.

Powered by Alpha Signal Monitor | Market Intelligence Through AI